GH Research (GHRS) Competitors $17.29 +1.30 (+8.13%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$18.35 +1.06 (+6.13%) As of 07/16/2025 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GHRS vs. MTSR, KYMR, IMVT, MOR, CRNX, ALVO, HCM, AMRX, CPRX, and BHCShould you be buying GH Research stock or one of its competitors? The main competitors of GH Research include Metsera (MTSR), Kymera Therapeutics (KYMR), Immunovant (IMVT), MorphoSys (MOR), Crinetics Pharmaceuticals (CRNX), Alvotech (ALVO), HUTCHMED (HCM), Amneal Pharmaceuticals (AMRX), Catalyst Pharmaceuticals (CPRX), and Bausch Health Cos (BHC). These companies are all part of the "pharmaceutical products" industry. GH Research vs. Its Competitors Metsera Kymera Therapeutics Immunovant MorphoSys Crinetics Pharmaceuticals Alvotech HUTCHMED Amneal Pharmaceuticals Catalyst Pharmaceuticals Bausch Health Cos Metsera (NASDAQ:MTSR) and GH Research (NASDAQ:GHRS) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations. Does the media favor MTSR or GHRS? In the previous week, GH Research had 3 more articles in the media than Metsera. MarketBeat recorded 7 mentions for GH Research and 4 mentions for Metsera. Metsera's average media sentiment score of 0.76 beat GH Research's score of 0.73 indicating that Metsera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Metsera 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GH Research 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation & earnings, MTSR or GHRS? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMetseraN/AN/A-$209.13MN/AN/AGH ResearchN/AN/A-$38.96M-$0.79-21.89 Is MTSR or GHRS more profitable? Metsera's return on equity of 0.00% beat GH Research's return on equity.Company Net Margins Return on Equity Return on Assets MetseraN/A N/A N/A GH Research N/A -19.20%-18.40% Do analysts rate MTSR or GHRS? Metsera currently has a consensus price target of $55.00, indicating a potential upside of 25.77%. GH Research has a consensus price target of $32.00, indicating a potential upside of 85.08%. Given GH Research's higher possible upside, analysts clearly believe GH Research is more favorable than Metsera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Metsera 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00GH Research 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in MTSR or GHRS? 56.9% of GH Research shares are owned by institutional investors. 41.6% of GH Research shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryGH Research beats Metsera on 6 of the 9 factors compared between the two stocks. Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GHRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GHRS vs. The Competition Export to ExcelMetricGH ResearchMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$831.93M$2.90B$5.51B$9.31BDividend YieldN/A2.46%4.25%4.08%P/E Ratio-21.8920.3628.1519.68Price / SalesN/A298.74439.01100.25Price / CashN/A42.3835.5357.53Price / Book5.037.768.235.67Net Income-$38.96M-$55.11M$3.23B$257.51M7 Day Performance7.73%0.19%-0.56%-0.16%1 Month Performance44.20%10.80%6.67%9.89%1 Year Performance46.40%-0.68%27.00%15.08% GH Research Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GHRSGH Research2.0229 of 5 stars$17.29+8.1%$32.00+85.1%+45.7%$831.93MN/A-21.8910News CoverageAnalyst RevisionMTSRMetseraN/A$28.39-3.6%$55.00+93.7%N/A$3.09BN/A0.0081KYMRKymera Therapeutics2.9352 of 5 stars$43.81-2.2%$59.11+34.9%-6.1%$2.92B$47.07M-14.13170IMVTImmunovant1.3688 of 5 stars$16.42-3.1%$38.33+133.5%-42.4%$2.90BN/A-5.99120MORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730CRNXCrinetics Pharmaceuticals3.4324 of 5 stars$29.06-2.5%$71.75+146.9%-42.0%$2.79B$1.04M-7.61210ALVOAlvotech2.8517 of 5 stars$9.02-1.8%$18.00+99.6%-30.6%$2.77B$491.98M24.381,032Gap UpHCMHUTCHMED1.617 of 5 stars$15.42-2.5%$19.00+23.2%-8.2%$2.76B$630.20M0.001,811Gap DownAMRXAmneal Pharmaceuticals2.8372 of 5 stars$8.41-0.1%$11.60+37.9%+8.7%$2.64B$2.79B-210.208,100CPRXCatalyst Pharmaceuticals4.8931 of 5 stars$20.95-2.4%$32.83+56.7%+24.7%$2.62B$491.73M13.3480BHCBausch Health Cos3.6963 of 5 stars$6.88-2.5%$7.42+7.8%-14.7%$2.61B$9.63B-62.5520,700 Related Companies and Tools Related Companies Metsera Alternatives Kymera Therapeutics Alternatives Immunovant Alternatives MorphoSys Alternatives Crinetics Pharmaceuticals Alternatives Alvotech Alternatives HUTCHMED Alternatives Amneal Pharmaceuticals Alternatives Catalyst Pharmaceuticals Alternatives Bausch Health Cos Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GHRS) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GH Research PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share GH Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
